Amphotericin B is mainly used for the treatment of severe invasive fungal infections (such as candidiasis, cryptococcosis, mucormycosis, aspergillosis, etc.), and it is a broad-spectrum antifungal drug. Quality research should focus on the stability of the formulation, the establishment of the impurity profile, the safety differences among different dosage forms, the control of nephrotoxicity and the risk of infusion reactions.
As Guangzhou PI PI Biotech Inc, a manufacturer with 15 years of specialized expertise in impurity research, we are capable of providing a full range of degradation impurities derived from process-related sources, long-term stability samples, accelerated stability samples, and forced degradation studies. We also offer complete structural characterization data, including HPLC, MASS, HNMR, CNMR, 2D-NMR techniques (such as COSY, HSQC, HMBC, and DEPT135), IR, TGA, QNMR, and SER. The product information is as follows:
| Catalog No. | Name |
| PI01012001 | Amphotericin B impurity A |
| PI01012002 | Amphotericin B impurity B |
| PI01012003 | Amphotericin B impurity C |
| PI01012004 | Amphotericin B impurity D |
| PI01012005 | Amphotericin B impurity 1 |
| PI01012006 | Amphotericin B impurity 2 |
| PI01012007 | Amphotericin B impurity 3 |
| PI01012008 | Amphotericin B impurity 4 |
| PI01012009 | Amphotericin B impurity 5 |
| PI01012010 | Amphotericin B impurity 6 |
| PI01012011 | Amphotericin B Glucose conjugate |
| PI01012012 | Ethylated amphotericin B |
| PI01012013 | Amphotericin B impurity 9 |
| PI01012014 | Amphotericin B impurity 10 |
| PI01012015 | Amphotericin B impurity 8 |
| PI01012016 | Amphotericin B impurity 12 |
| PI01012017 | Amphotericin B CP impurity D |
| PI01012018 | Amphotericin B CP impurity E |
| PI01012019 | Amphotericin B impurity 19 |
For inquiries, please contact us at:
E-mail: sales@pipitech.com
WhatsApp & WeChat: +86 136 0240 9664
China
